XML 31 R19.htm IDEA: XBRL DOCUMENT
v3.25.1

Fair Value Measurements and Financial Instruments | 3 Months Ended
--- | ---
Mar. 31, 2025
Fair Value Disclosures [Abstract] |
Fair Value Measurements and Financial Instruments | Fair Value Measurements and Financial Instruments The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations. The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. The Company’s derivative instruments include foreign currency contracts and commodity contracts. The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months. The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Condensed Consolidated Balance Sheets at March 31, 2025 and December 31, 2024:
| Assets |  |  | Liabilities
| Account |  |  | Fair Value |  |  | Account |  |  | Fair Value
Designated derivative instruments |  |  | March 31, 2025 |  |  | December 31, 2024 |  |  |  |  |  | March 31, 2025 |  |  | December 31, 2024
Foreign currency contracts | Other current assets |  |  | $ | 28 |  |  |  | $ | 33 |  |  |  | Other accruals |  |  | $ | 15 |  |  |  | $ | 22 |
Commodity contracts | Other current assets |  |  | — |  |  |  | — |  |  |  | Other accruals |  |  | 1 |  |  |  | 1 |
Total designated |  |  | $ | 28 |  |  |  | $ | 33 |  |  |  |  |  |  | $ | 16 |  |  |  | $ | 23 |
Other financial instruments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Marketable securities | Other current assets |  |  | $ | 199 |  |  |  | $ | 160 |  |  |  |  |  |  |  |  |  |
Total other financial instruments |  |  | $ | 199 |  |  |  | $ | 160 |  |  |  |  |  |  |  |  |  |
The carrying amount of cash, cash equivalents, marketable securities and accounts receivable approximated fair value as of March 31, 2025 and December 31, 2024. The estimated fair value of the Company’s total debt as of March 31, 2025 and December 31, 2024, was $7,776 and $7,441, respectively, and the related carrying value was $8,269 and $7,949, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation). The following tables present the notional values as of:
| March 31, 2025
| Foreign Currency Contracts |  | Foreign Currency Debt |  |  |  |  |  | Commodity Contracts |  | Total
Fair Value Hedges | $ | 1,829 |  |  | $ | — |  |  |  |  |  |  | $ | — |  |  | $ | 1,829 |
Cash Flow Hedges | 1,036 |  |  | — |  |  |  |  |  |  | 15 |  |  | 1,051 |
Net Investment Hedges | 340 |  |  | 3,831 |  |  |  |  |  |  | — |  |  | 4,171 |
| December 31, 2024
| Foreign Currency Contracts |  | Foreign Currency Debt |  |  |  |  |  | Commodity Contracts |  | Total
Fair Value Hedges | $ | 1,669 |  |  | $ | — |  |  |  |  |  |  | $ | — |  |  | $ | 1,669 |
Cash Flow Hedges | 1,023 |  |  | — |  |  |  |  |  |  | 18 |  |  | 1,041 |
Net Investment Hedges | 289 |  |  | 3,750 |  |  |  |  |  |  | — |  |  | 4,039 |
The amount of gain (loss) recognized in income associated with fair value hedges did not have a material impact on the Company’s Condensed Consolidated Financial Statements during the three months ended March 31, 2025. The amount of gain (loss) recognized in income and Accumulated Other Comprehensive Income (AOCI) associated with cash flow hedges did not have a material impact on the Company’s Condensed Consolidated Financial Statements during the three months ended March 31, 2025. The following table presents the amount of gain (loss) on net investment hedges recognized in the Company’s AOCI:
|  | Gain (Loss) Recognized in AOCI
|  | Three Months Ended March 31,
|  | 2025 |  | 2024
Hedging instruments: |  |  |  |
Foreign currency contracts |  | $ | (7) |  |  | $ | 2 |
Foreign currency debt |  | (167) |  |  | 106 |
Total gain (loss) on net investment hedges |  | $ | (174) |  |  | $ | 108 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration